glp 1 analogue GLP-1 History of glucagon-like peptide-1 receptor
Description
People concerned about dependence
Approved for chronic weight management in adults with obesity or weight-related conditions
Bridging therapies may be considered but can be costly and risky
The FDA approved Wegovy, the first GLP-1 exclusively for weight loss, in 2021, and in the past five years, prescriptions for this class of drugs have more than quadrupled
Smits MM, Tonneijck L, Muskiet MH, Hoekstra T, Kramer MH, Diamant M, et al
